Tilbury Douglas appointed to deliver state-of-the-art AI-powered laboratory facilities at LSTM
Tilbury Douglas, a leading UK building, infrastructure, engineering and fit-out business, has been appointed to deliver new High Containment Level 3 laboratories at the Liverpool School of Tropical Medicine (LSTM), a flagship project backed by £10 million Innovation Zone funding.
This major development will see the creation of advanced robotic laboratories equipped with cutting edge AI and automated systems. The new facilities will support LSTM and the LSTM-led Infection Innovation Consortium (iiCON) in accelerating the development of life saving vaccines, drugs and diagnostics targeting high risk infectious diseases.
The scheme marks a continuation of a strong and trusted relationship between Tilbury Douglas and LSTM, building on a track record of successful project delivery. It also strengthens Tilbury Douglas’ strategic role in the Liverpool City Region’s Life Sciences Innovation Zone programme.
Commenting on the appointment, Martin Horne, Regional Director – North West at Tilbury Douglas, said: “We’re proud to be playing a part in bringing this transformative project to life. Delivering these pioneering laboratories for LSTM and iiCON, as part of our long-standing collaboration, reinforces our commitment to enabling world class innovation through exceptional construction delivery. The integration of AI and robotic systems will have a profound impact on global health, and we’re pleased to help create a space where this vital work can thrive.”
Located at the heart of Liverpool’s internationally recognised health and life sciences cluster, the new facility will support LSTM and iiCON’s leading research into deadly pathogens and accelerate human organoid research to better replicate disease and treatment responses.
As part of a wider £20 million programme funded by UKRI’s Expanding Excellence in England (E3) fund and the Wolfson Foundation, this project is expected to attract £40 million of investment within its first three years, generating high-quality employment and helping maintain the Liverpool City Region’s global leadership in infection innovation.
Tilbury Douglas brings extensive experience in delivering complex, highly specialised environments within healthcare, science and research. This appointment reflects its ongoing focus on partnerships that deliver long-term social, economic and health value.